Publication & Citation Trends
Publications
0 total
Concurrent Improvement Over Time in Multiple Aspects of Quality of Life in Patients with Chronic Spontaneous Urticaria Treated with Omalizumab
Cited by 0
Semantic Scholar
Racial Differences in Demographic and Baseline Disease Characteristics in Patients with Chronic Spontaneous Urticaria
Cited by 0
Semantic Scholar
Matching-adjusted indirect comparison analysis of omalizumab versus dupilumab in patients with chronic spontaneous urticaria
Cited by 0
Semantic Scholar
Omalizumab Efficacy In Patients With Chronic Spontaneous Urticaria And Comorbid Asthma
Cited by 0
Semantic Scholar
BETTER IMPROVEMENT FOR OMALIZUMAB VERSUS DUPILUMAB/REMIBRUTINIB FOR CSU: WEEK 12 DISEASE ACTIVITY MATCHED-ADJUSTED INDIRECT COMPARISON
Cited by 0
Semantic Scholar
Does angioedema in patients with chronic spontaneous urticaria impact response to omalizumab? OA
Cited by 1
Semantic Scholar
Effectiveness of omalizumab across different dosing regimens in patients with moderate-to-severe allergic asthma.
Cited by 2
Semantic Scholar
Research Topics
Asthma and respiratory diseases
(41)
Allergic Rhinitis and Sensitization
(20)
Urticaria and Related Conditions
(20)
Respiratory and Cough-Related Research
(13)
Inhalation and Respiratory Drug Delivery
(12)
Affiliations
Fleet Science Center
Novartis (Switzerland)
Amgen (United States)
Eli Lilly (United States)
University of California, San Francisco